The Wyoming Department of Health is conducting a survey concerning the use and barriers to use of 17-alpha hydroxyprogesterone in pregnant women. If you routinely provide prenatal care for your pregnant patients, please participate in this survey.
The Draft 2017 PDL is available for review. Please submit comments before January 1, 2017.
Preferred Drug List (PDL)
The Wyoming Medicaid Preferred Drug List (PDL) including step utilization for anti-depressant medications and prior authorization information is available at the Wyoming EqualityCare Pharmacy Provider website. To view the current PDL, please visit www.wymedicaid.org.
A new policy for public comment at meetings is effective December 2, 2012.
PhRMA Guidelines and PhRMA Comment Request Form (updated November 5, 2015)
Public Guidelines and Public Comment Request Form (updated November 5, 2015)
The following prior authorization criteria were approved at the February 9, 2017 P & T Committee meeting.
Comments may be sent by email to email@example.com or by mail to: Wyoming Drug Utilization Review Board, Dept. 3375, 1000 E. University Avenue, Laramie, WY 82071. Comments should be received prior to April 1, 2017.
Agenda February 9, 2017
Minutes February 9, 2017
Thursday, February 9; Wednesday, May 10; Thursday, August 10; Thursday, November 9
All meetings are at 10 am at Laramie County Community College. Please see agenda for room location.